John Arlotta serves as Executive at Express Scripts Holding Co., where they oversee executive responsibilities. Since joining the company, John Arlotta has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 15, 2024 involved receiving (via award) 9,150 shares valued at $0.
John Arlotta currently holds 71,009 shares of Express Scripts Holding Co. (ESRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Arlotta has been a net neutral trader of ESRX stock. They have purchased $0 and sold $0 worth of shares.
John Arlotta's most recent insider trade was on May 15, 2024, when they sold 9,150 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 20, 2022 | OPCH | $0 | Award | 8,481 | $N/A | Discretionary |
| May 26, 2021 | OPCH | $0 | Award | 13,851 | $N/A | Discretionary |
| Jun 22, 2020 | OPCH | $0 | Award | 15,348 | $N/A | Discretionary |
| Dec 11, 2019 | BIOS | $0 | Award | 61,940 | $N/A | Discretionary |
| Dec 20, 2018 | ESRX | $0 | Disposition | 6,688 | $N/A | Discretionary |
| Mar 6, 2018 | ESRX | $0 | Award | 6,688 | $N/A | Discretionary |